Skip to main content
Nidhi Agrawal, MD, Endocrinology, New York, NY

NidhiAgrawalMD

Endocrinology New York, NY

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Pituitary Disorders & Neuroendocrinology

Clinical Assistant Professor, faculty and researcher

Dr. Agrawal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Agrawal's full profile

Already have an account?

  • Office

    550 1st Ave
    New York, NY 10016
    Phone+1 212-263-5506

Summary

  • Dr. Nidhi Agrawal is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including NYU Langone Hospitals and NYC Health + Hospitals / Bellevue.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2016
  • Manipal College of Medical Science
    Manipal College of Medical ScienceClass of 2009
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine
  • MedStar Health/Georgetown-Washington Hospital Center
    MedStar Health/Georgetown-Washington Hospital CenterInternship, Internal Medicine

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology and Metabolism
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Teacher/ Faculty of the year award NYU
  • Endocrinology Fellow of the Year NYU Langone Medical Center
  • Early Career Award Endocrine Society
  • Join now to see all

Publications & Presentations

PubMed

Books/Book Chapters

Grant Support

  • Amgen Diabetes Study Subinvestigator. Amgen Diabetes-Hypercholesterolemia/Mixed Dyslipidemia- Clinical Trial Program testing evolocumab for patients with elevated LDL-C and heart disease or at risk of heart diseaseNYUPresent

Professional Memberships